CRIS Current Research Information System

MUSIANI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.579
AS - Asia 5.010
EU - Europa 4.754
AF - Africa 322
SA - Sud America 224
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 15.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.535
CN - Cina 1.645
SG - Singapore 1.360
GB - Regno Unito 1.357
VN - Vietnam 1.080
DE - Germania 627
IT - Italia 573
UA - Ucraina 569
SE - Svezia 553
HK - Hong Kong 316
IN - India 307
RU - Federazione Russa 301
FR - Francia 212
IE - Irlanda 173
BR - Brasile 164
JP - Giappone 119
ZA - Sudafrica 99
EE - Estonia 93
KR - Corea 87
CH - Svizzera 81
TG - Togo 78
SC - Seychelles 54
CI - Costa d'Avorio 51
NL - Olanda 43
BG - Bulgaria 41
BE - Belgio 35
CA - Canada 33
IR - Iran 30
NG - Nigeria 30
AR - Argentina 27
FI - Finlandia 25
GR - Grecia 17
AT - Austria 16
JO - Giordania 16
RO - Romania 13
ID - Indonesia 11
UZ - Uzbekistan 10
EC - Ecuador 7
LB - Libano 7
MX - Messico 7
CO - Colombia 6
PL - Polonia 6
PY - Paraguay 6
CL - Cile 5
IQ - Iraq 5
BD - Bangladesh 4
EU - Europa 4
UY - Uruguay 4
AZ - Azerbaigian 3
DZ - Algeria 3
EG - Egitto 3
ES - Italia 3
IL - Israele 3
LT - Lituania 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
KZ - Kazakistan 2
PE - Perù 2
PR - Porto Rico 2
TR - Turchia 2
AL - Albania 1
AU - Australia 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SM - San Marino 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 15.895
Salva come PNG Salva come JPEG
Città #
Southend 1.162
Singapore 826
Ashburn 549
Chandler 541
Dong Ket 501
Fairfield 455
Jacksonville 430
Hefei 315
Hong Kong 314
Wilmington 260
Princeton 246
Ann Arbor 237
Woodbridge 236
Seattle 228
Houston 214
Beijing 181
Dublin 173
Boardman 164
Cambridge 160
Santa Clara 139
Ho Chi Minh City 119
Tokyo 119
Westminster 119
Padova 118
Nanjing 107
Berlin 94
Hanoi 89
Seoul 85
Los Angeles 81
Medford 79
Lomé 78
Bern 74
Buffalo 72
Mülheim 69
Saint Petersburg 66
Milan 65
New York 59
Shenyang 54
Mahé 52
Abidjan 51
Jinan 51
Changsha 42
Sofia 41
Redwood City 40
Bengaluru 37
Nanchang 37
Bologna 35
Brussels 35
Dallas 35
Tianjin 35
Shanghai 31
Abeokuta 30
Zhengzhou 30
Hebei 28
Guangzhou 27
Florence 26
Verona 26
Hangzhou 25
Bremen 24
Jiaxing 24
Helsinki 23
Des Moines 21
Olalla 20
San Diego 20
Haiphong 19
Taizhou 19
Dearborn 17
Paris 17
Toronto 17
Amman 16
Norwalk 16
Phoenix 15
Kunming 14
Ningbo 14
Redondo Beach 14
Frankfurt am Main 13
San Venanzo 13
Yubileyny 13
Haikou 12
Hyderabad 12
Rome 12
Taiyuan 12
Falls Church 11
Kuban 11
Pune 11
São Paulo 11
Wuhan 11
Ardabil 10
London 10
Rio de Janeiro 10
Tappahannock 10
Turin 10
Vienna 10
Curitiba 9
Da Nang 9
Falkenstein 9
Lanzhou 9
Shenzhen 9
Stockholm 9
Bühl 8
Totale 10.166
Salva come PNG Salva come JPEG
Nome #
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 228
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 219
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 199
Bio- and chemiluminescence imaging in analytical chemistry 199
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 194
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 190
A miniaturized multiplexed analytical device with chemiluminescence "contact" imaging detection for diagnostic applications 189
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 188
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 185
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 183
Bio-chemiluminescent miniaturized biosensors 181
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 179
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 178
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 175
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 174
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 174
Analysis of HPV16 E6*I-II transcripts in cervical samples 174
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 173
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 173
Combined fluorescent DNA in situ hybridization and chemiluminescent immunohistochemistry for the co-localization of mucosal human papillomavirus and malignant melanoma 169
A proteomic approach to the analysis of B19 capsid proteins 169
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 164
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 163
Recurrent erythema in patients with long-term parvovirus B19 infection 162
Analisi della competenza funzionale di cloni genomici di parvovirus B19 159
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 158
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 157
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 157
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 152
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 152
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 151
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 150
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 149
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 149
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 149
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 147
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 147
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 146
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 145
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 144
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 143
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 141
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 141
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 140
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 140
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 140
Analysis of the functional competence of genomic clones of Parvovirus B19 137
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 136
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 136
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 136
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 136
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 136
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 135
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 135
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 134
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 134
Parvovirus B19-derived fetal complications following gestational infection. 133
Evidence of human bocavirus viremia in healthy blood donors. 133
No correlation between cytomegalovirus and alopecia areata [2] 133
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 132
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 131
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 131
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la colocalizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 130
Diagnosi virologica di infezione da papillomavirus umani 129
Molecular luminescence imaging 129
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 129
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 127
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 126
Implicazioni nella progressione della patologia cervicale 126
Human papillomavirus in melanoma: reply from authors 126
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 125
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 123
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 122
Catalytic partial oxidation of CH4-H2mixtures over Ni foams modified with Rh and Pt 121
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 120
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 119
Development of a miniaturized analytical device employing luminescence “contact” imaging detection for parvovirus B19 infection diagnosis 119
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 118
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 118
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 118
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 117
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 117
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 116
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 116
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 116
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 114
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 114
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 113
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 110
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 110
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 109
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 107
Quantitative immunohistochemistry and in situ hybridisation imaging procedures with luminescence detection: a new potential diagnostic tool 106
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 104
Detection of parvovirus B19 IgG: choice of antigens and serological tests 103
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 102
Multiplex chemiluminescence microscope imaging of P16INK4A and HPV DNA as biomarker of cervical neoplasia 102
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 102
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 100
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 95
Totale 14.185
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.616
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.405 0 0 0 0 0 125 37 106 121 107 108 801
2021/20222.130 164 110 140 224 179 116 22 116 67 226 354 412
2022/20232.297 247 339 126 272 177 139 57 137 358 45 236 164
2023/2024798 42 94 39 128 44 165 108 63 18 33 21 43
2024/20252.057 80 359 221 144 304 112 225 45 17 53 60 437
2025/20262.794 350 712 536 427 605 164 0 0 0 0 0 0
Totale 16.148